Real-World Data From a Molecular Tumor Board: Improved Outcomes in Breast and Gynecologic Cancers Patients With Precision Medicine.
Lindsey M CharoRamez N EskanderJason K SicklickKi Hwan KimHyo Jeong LimRyosuke OkamuraSuzanna LeeRupa SubramanianRichard B SchwabRebecca ShatskySteven PlaxeShumei KatoRazelle KurzrockPublished in: JCO precision oncology (2022)
Compliance to MTB recommendations resulted in higher degrees of matched therapy and correlates with improved outcomes in patients with gynecologic and breast cancers.